Another IP achievement for Alembic at USPTO

Sponsored Links

Alembic Ltd, a Vadodara based pharmaceutical company enagaged in pharmaceutical API as well as finished product development in domestic as well as in international. Recently alembic got patent grant from USPTO for one of its product Venlafaxine hydrochloride extended release formulation. The granted US patent no 7,807,195 is about an extended release once daily pharmaceutical formulation comprising venlafaxine hydrochloride in the form of hard gelatin capsules filled with mini tablets.

About the Author

Sanjay Patel's picture
Author: Sanjay Patel

You May Also Like..